Sleep Number Announces Second Quarter 2024 Results

Rhea-AI Summary

Sleep Number (Nasdaq: SNBR) reported Q2 2024 results, generating adjusted EBITDA of $28 million. Despite an 11% decline in net sales to $408 million, the company achieved a gross margin rate of 59.1%, up 150 basis points year-over-year. Operating expenses were reduced by $19 million for the quarter. The company reiterated its full-year 2024 adjusted EBITDA outlook of $125 million to $145 million.

Key highlights include:

• Year-to-date free cash flow increased $21 million compared to last year
• Prioritizing debt reduction and lowering leverage
• Expecting mid-single digit net sales decline for the year
• Anticipating at least 100 basis points of gross margin rate improvement
• Projecting $50 million to $70 million of free cash flow for 2024

Positive

• Gross margin rate improved to 59.1%, up 150 basis points year-over-year
• Operating expenses reduced by $19 million in Q2 and $44 million year-to-date
• Year-to-date free cash flow increased by $21 million compared to last year
• Reiterated full-year 2024 adjusted EBITDA outlook of $125-145 million
• Expecting at least 100 basis points of gross margin rate improvement for the year

Negative

• Net sales declined 11% to $408 million in Q2
• Adjusted EBITDA decreased from $35 million in Q2 2023 to $28 million in Q2 2024
• Leverage ratio of 4.4x EBITDAR at the end of Q2
• Expecting mid-single digit net sales decline for the full year 2024
• Challenging industry sales environment and persistent macroeconomic headwinds

Insights

Financial Analyst

Sleep Number's Q2 2024 results reveal a mixed picture, with some positive developments amidst ongoing challenges. The company's focus on operational efficiency is evident, but the broader industry headwinds continue to impact performance.

Key positives:

• Gross margin improvement: The 59.1% gross margin, up 150 basis points year-over-year, demonstrates effective cost management and operational enhancements.
• Expense reduction: Operating expenses decreased by $19 million for the quarter and $44 million year-to-date, indicating successful cost-cutting measures.
• Improved cash flow: Year-to-date free cash flow increased by $21 million compared to the previous year, suggesting better working capital management.

Challenges:

• Revenue decline: Net sales of $408 million were down 11% year-over-year, reflecting a challenging industry sales environment.
• Adjusted EBITDA decrease: Q2 adjusted EBITDA of $28 million compared to $35 million last year, primarily due to lower sales.
• High leverage: The leverage ratio of 4.4x EBITDAR, while within covenant limits, remains elevated and could limit financial flexibility.

The company's ability to maintain its full-year adjusted EBITDA outlook of $125 million to $145 million despite headwinds is noteworthy. However, the projected mid-single-digit net sales decline for the year suggests ongoing market challenges. The focus on debt reduction and improved profitability positions Sleep Number to potentially benefit from an industry recovery, but the timing of such a recovery remains uncertain.

Market Research Analyst

Sleep Number's Q2 2024 results offer valuable insights into both company-specific strategies and broader industry trends. The persistent macroeconomic headwinds and prolonged industry recession mentioned by CEO Shelly Ibach are important factors shaping the current market landscape.

Industry context:

• The mattress and sleep technology sector appears to be facing a prolonged downturn, likely influenced by reduced consumer spending on discretionary items.
• Sleep Number's expectation of flat to low-single-digit decline in demand and net sales for the second half of 2024 suggests a potential stabilization, albeit at lower levels.

Company strategy:

• Sleep Number's focus on 'transformative initiatives' seems to be yielding results, particularly in gross margin improvement and cost reduction.
• The emphasis on paying down debt and reducing leverage indicates a defensive posture, prioritizing financial stability over aggressive growth.

Market implications:

• The company's ability to improve gross margins in a challenging environment may pressure competitors to focus on similar operational efficiencies.
• The projected $50 million to $70 million free cash flow for the year, despite sales challenges, could provide Sleep Number with a competitive advantage for future investments or market share gains when the industry recovers.

While Sleep Number's operational improvements are commendable, the ongoing industry recession highlights the need for companies in this sector to adapt to changing consumer behaviors and economic conditions. The company's performance in the coming quarters will be important in assessing whether these strategies can drive growth once market conditions improve.

• Generated adjusted EBITDA of $28 million for the second quarter
• Delivered gross margin rate of 59.1% for the second quarter, up 150 basis points versus last year and ahead of expectations
• Reduced operating expenses by $19 million year-over-year for the quarter and $44 million year-to-date (both periods before restructuring costs)
• Year-to-date free cash flow increased $21 million compared with the same period last year
• Reiterate full-year 2024 adjusted EBITDA outlook of $125 million to $145 million

MINNEAPOLIS--(BUSINESS WIRE)-- Sleep Number Corporation (Nasdaq: SNBR) today reported results for the quarter ended June 29, 2024.

“The implementation of our transformative initiatives is improving gross margin, operating expenses and free cash flow, as our teams continue to execute sustainable changes across the business. In the second quarter, we delivered gross margin rate expansion and adjusted EBITDA slightly ahead of expectations, despite facing a more challenging industry sales environment than anticipated,” said Shelly Ibach, Chair, President and CEO. “In this environment, we continue to prioritize paying down debt and reducing leverage. Our more durable operating model is enabling us to effectively navigate the persistent macroeconomic headwinds and prolonged industry recession, while positioning us for even greater profitability when the industry recovers.”

Second Quarter Overview

• Net sales of $408 million were down 11% versus the prior year, including approximately six percentage points of pressure from year-over-year order backlog changes
• Gross margin of 59.1% was up 150 basis points versus the prior year, driven by ongoing product cost reductions through value engineering and supplier negotiations, efficiency gains in our home delivery and logistics operations and improved product returns rates
• Operating expenses of $234 million (before restructuring charges) were down $19 million versus the prior year’s second quarter, including broad-based cost reductions across the business
• Adjusted EBITDA of $28 million compared to $35 million last year, with a higher gross margin rate and $19 million operating expense improvement, partially offsetting the year-over-year net sales decline

Cash Flows and Liquidity Review

• Net cash provided by operating activities of $24 million for the first six months of the year, a $5 million increase versus the same period last year
• Free cash flow of $9 million for the first six months of the year, up $21 million versus the same period last year
• Leverage ratio of 4.4x EBITDAR at the end of the second quarter versus covenant maximum of 5.5x for the quarter

Financial Outlook

The company reiterates its outlook for 2024 adjusted EBITDA of $125 million to $145 million. We expect a mid-single digit net sales decline for the year. For the second half of the year, we expect demand and net sales to be flat to down low-single digits versus the prior year, as we lap easier comparisons from the prior year and benefit from demand driving initiatives. The company expects at least 100 basis points of gross margin rate improvement and $14 million of restructuring charges for the year. The company now expects to generate $50 million to $70 million of free cash flow with capital expenditures of $30 million.

Conference Call Information

Management will host its regularly scheduled conference call to discuss the company’s results at 5 p.m. EDT (4 p.m. CDT; 2 p.m. PDT) today. To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days. We have also posted an updated investor presentation to the investor relations area of the Sleep Number website.

About Sleep Number Corporation

Sleep Number is a wellness technology company. We are guided by our purpose to improve the health and wellbeing of society through higher quality sleep; to date, our innovations have improved over 15 million lives. Our wellness technology platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through our Climate360^® smart bed or applying our nearly 28 billion hours of longitudinal sleep data and expertise to research with global institutions.

Our smart bed ecosystem drives best-in-class engagement through dynamic, adjustable, and effortless sleep with personalized digital sleep and health insights; our millions of Smart Sleepers are loyal brand advocates. And our 3,800 mission-driven team members passionately innovate to drive value creation through our vertically integrated business model, including our exclusive direct-to-consumer selling in nearly 650 stores and online.

To learn more about life-changing, individualized sleep, visit a Sleep Number^® store near you, our newsroom and investor relations sites, or SleepNumber.com

Forward-looking Statements

Statements used in this news release relating to future plans, events, financial results or performance, such as the statement that the company continues to prioritize paying down debt and reducing leverage and that the company’s more durable operating model is enabling the company to effectively navigate the persistent macroeconomic headwinds and prolonged industry recession, while positioning the company for even greater profitability, and the company’s financial outlook, including the company’s expected 2024 adjusted EBITDA and future net sales, demand, gross margin, and free cash flow expectations, are forward-looking statements subject to certain risks and uncertainties which could cause the company’s results to differ materially. The most important risks and uncertainties are described in the company’s filings with the Securities and Exchange Commission, including in Item 1A of the company’s Annual Report on Form 10-K and other periodic reports. Forward-looking statements speak only as of the date they are made, and the company does not undertake any obligation to update any forward-looking statement.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES Consolidated Statements of Operations (unaudited – in thousands, except per share amounts)
	Three Months Ended
	June 29, 2024				% of Net Sales			July 1, 2023			% of Net Sales
Net sales	$	408,413			100.0	%		$	458,789		100.0	%
Cost of sales		166,923			40.9	%			194,544		42.4	%
Gross profit		241,490			59.1	%			264,245		57.6	%
Operating expenses:
Sales and marketing		182,400			44.7	%			197,779		43.1	%
General and administrative		39,573			9.7	%			39,795		8.7	%
Research and development		11,578			2.8	%			15,445		3.4	%
Restructuring costs		1,819			0.4	%			—		0.0	%
Total operating expenses		235,370			57.6	%			253,019		55.1	%
Operating income		6,120			1.5	%			11,226		2.4	%
Interest expense, net		12,270			3.0	%			9,948		2.2	%
(Loss) income before income taxes		(6,150	)		(1.5	%)			1,278		0.3	%
Income tax (benefit) expense		(1,099	)		(0.3	%)			524		0.1	%
Net (loss) income	$	(5,051	)		(1.2	%)		$	754		0.2	%
Net (loss) income per share – basic	$	(0.22	)					$	0.03
Net (loss) income per share – diluted	$	(0.22	)					$	0.03
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding		22,614							22,460
Dilutive effect of stock-based awards		—							42
Diluted weighted-average shares outstanding		22,614							22,502
For the three months ended June 29, 2024, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES Consolidated Statements of Operations (unaudited – in thousands, except per share amounts)
	Six Months Ended
	June 29, 2024				% of Net Sales			July 1, 2023			% of Net Sales
Net sales	$	878,862			100.0	%		$	985,316		100.0	%
Cost of sales		361,198			41.1	%			410,806		41.7	%
Gross profit		517,664			58.9	%			574,510		58.3	%
Operating expenses:
Sales and marketing		390,912			44.5	%			428,267		43.5	%
General and administrative		78,652			8.9	%			79,196		8.0	%
Research and development		24,019			2.7	%			29,888		3.0	%
Restructuring costs		12,419			1.4	%			—		0.0	%
Total operating expenses		506,002			57.6	%			537,351		54.5	%
Operating income		11,662			1.3	%			37,159		3.8	%
Interest expense, net		24,569			2.8	%			19,050		1.9	%
(Loss) income before income taxes		(12,907	)		(1.5	%)			18,109		1.8	%
Income tax (benefit) expense		(374	)		0.0	%			5,890		0.6	%
Net (loss) income	$	(12,533	)		(1.4	%)		$	12,219		1.2	%
Net (loss) income per share – basic	$	(0.56	)					$	0.55
Net (loss) income per share – diluted	$	(0.56	)					$	0.54
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding		22,560							22,378
Dilutive effect of stock-based awards		—							165
Diluted weighted-average shares outstanding		22,560							22,543
For the six months ended June 29, 2024, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (unaudited – in thousands, except per share amounts) subject to reclassification
	June 29, 2024				December 30, 2023
Assets
Current assets:
Cash and cash equivalents	$	2,020			$	2,539
Accounts receivable, net of allowances of $1,098 and $1,437, respectively		20,272				26,859
Inventories		95,845				115,433
Prepaid expenses		21,322				16,660
Other current assets		37,925				44,637
Total current assets		177,384				206,128
Non-current assets:
Property and equipment, net		153,676				179,503
Operating lease right-of-use assets		373,518				395,411
Goodwill and intangible assets, net		66,523				66,634
Deferred income taxes		25,397				20,253
Other non-current assets		87,147				82,951
Total assets	$	883,645			$	950,880
Liabilities and Shareholders’ Deficit
Current liabilities:
Borrowings under revolving credit facility	$	540,200			$	539,500
Accounts payable		106,039				135,901
Customer prepayments		44,518				49,143
Accrued sales returns		20,531				22,402
Compensation and benefits		35,305				28,273
Taxes and withholding		16,563				17,134
Operating lease liabilities		80,914				81,760
Other current liabilities		56,500				61,958
Total current liabilities		900,570				936,071
Non-current liabilities:
Operating lease liabilities		327,810				351,394
Other non-current liabilities		102,229				105,343
Total non-current liabilities		430,039				456,737
Total liabilities		1,330,609				1,392,808
Shareholders’ deficit:
Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding		—				—
Common stock, $0.01 par value; 142,500 shares authorized, 22,355 and 22,235 shares issued and outstanding, respectively		224				222
Additional paid-in capital		24,211				16,716
Accumulated deficit		(471,399	)			(458,866	)
Total shareholders’ deficit		(446,964	)			(441,928	)
Total liabilities and shareholders’ deficit	$	883,645			$	950,880

SLEEP NUMBER CORPORATION AND SUBSIDIARIES Consolidated Statements of Cash Flows (unaudited – in thousands) subject to reclassification
	Six Months Ended
	June 29, 2024				July 1, 2023
Cash flows from operating activities:
Net (loss) income	$	(12,533	)		$	12,219
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization		34,177				36,749
Stock-based compensation		8,109				9,890
Net loss on disposals and impairments of assets		2,500				181
Deferred income taxes		(5,144	)			(8,272	)
Changes in operating assets and liabilities:
Accounts receivable		6,587				1,903
Inventories		19,588				(7,412	)
Income taxes		774				1,808
Prepaid expenses and other assets		(1,483	)			(5,824	)
Accounts payable		(18,464	)			(10,244	)
Customer prepayments		(4,625	)			(14,683	)
Accrued compensation and benefits		7,153				7,594
Other taxes and withholding		(1,345	)			(2,074	)
Other accruals and liabilities		(11,776	)			(3,115	)
Net cash provided by operating activities		23,518				18,720
Cash flows from investing activities:
Purchases of property and equipment		(14,075	)			(29,899	)
Issuance of notes receivable		(2,942	)			(435	)
Net cash used in investing activities		(17,017	)			(30,334	)
Cash flows from financing activities:
Net (decrease) increase in short-term borrowings		(6,408	)			14,693
Repurchases of common stock		(612	)			(3,501	)
Proceeds from issuance of common stock		—				428
Net cash (used in) provided by financing activities		(7,020	)			11,620
Net (decrease) increase in cash and cash equivalents		(519	)			6
Cash and cash equivalents, at beginning of period		2,539				1,792
Cash and cash equivalents, at end of period	$	2,020			$	1,798

SLEEP NUMBER CORPORATION AND SUBSIDIARIES Supplemental Financial Information (unaudited)
	Three Months Ended								Six Months Ended
	June 29, 2024				July 1, 2023				June 29, 2024				July 1, 2023
Percent of sales:
Retail stores		87.8	%			87.7	%			88.0	%			87.4	%
Online, phone, chat and other		12.2	%			12.3	%			12.0	%			12.6	%
Total Company		100.0	%			100.0	%			100.0	%			100.0	%
Sales change rates:
Retail comparable-store sales		(11	%)			(20	%)			(10	%)			(10	%)
Online, phone and chat		(13	%)			(3	%)			(16	%)			(12	%)
Total Retail comparable sales change		(11	%)			(18	%)			(11	%)			(10	%)
Net opened/closed stores and other		0	%			2	%			0	%			2	%
Total Company		(11	%)			(16	%)			(11	%)			(8	%)
Stores open:
Beginning of period		661				671				672				670
Opened		4				7				10				19
Closed		(19	)			(6	)			(36	)			(17	)
End of period		646				672				646				672
Other metrics:
Average sales per store ($ in 000's) 1	$	2,732			$	3,089
Average sales per square foot 1	$	883			$	1,007
Stores > $2 million net sales 2		62	%			71	%
Stores > $3 million net sales 2		21	%			31	%
Average revenue per smart bed unit 3	$	5,802			$	5,990			$	5,782			$	5,913

1		Trailing twelve months Total Retail comparable sales per store open at least one year.
2		Trailing twelve months for stores open at least one year (excludes online, phone and chat sales).
3		Represents Total Retail (stores, online, phone and chat) net sales divided by Total Retail smart bed units.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) (in thousands)   We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation, restructuring costs and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure:
	Three Months Ended							Trailing Twelve Months Ended
	June 29, 2024				July 1, 2023			June 29, 2024				July 1, 2023
Net (loss) income	$	(5,051	)		$	754		$	(40,039	)		$	11,822
Income tax (benefit) expense		(1,099	)			524			(10,730	)			6,602
Interest expense		12,270				9,948			48,214				32,289
Depreciation and amortization		16,347				18,304			69,676				71,318
Stock-based compensation		3,992				5,252			13,073				15,071
Restructuring costs 1		1,819				—			28,147				—
Asset impairments		—				170			490				294
Adjusted EBITDA	$	28,278			$	34,952		$	108,831			$	137,396
1 Represents costs related to business restructuring actions initiated in the fourth quarter of fiscal 2023.

Free Cash Flow (in thousands)
	Six Months Ended							Trailing Twelve Months Ended
	June 29, 2024			July 1, 2023				June 29, 2024				July 1, 2023
Net cash provided by (used in) operating activities	$	23,518		$	18,720			$	(4,230	)		$	26,167
Subtract: Purchases of property and equipment		14,075			29,899				41,232				62,794
Free cash flow	$	9,443		$	(11,179	)		$	(45,462	)		$	(36,627	)
Note - Our Adjusted EBITDA calculations and Free Cash Flow data are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.
GAAP - generally accepted accounting principles in the U.S.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES Calculation of Net Leverage Ratio under Revolving Credit Facility (in thousands)   Our calculation of Net Leverage Ratio under Revolving Credit Facility was changed effective with the amendment of our credit facility on November 2, 2023. Prior to the amendment, the calculation included capitalized operating lease obligations based on a multiple of six times annual rent expense. The amendment replaced this line item with operating lease liabilities included in our financial statements under ASC 842. The calculations in accordance with the November 2, 2023 amendment are presented below. The prior year is presented in conformity with the November 2, 2023 amendment.
	Trailing Twelve Months Ended
	June 29, 2024			July 1, 2023
Borrowings under revolving credit facility	$	540,200		$	483,800
Outstanding letters of credit		7,147			7,147
Finance lease obligations		280			361
Consolidated funded indebtedness	$	547,627		$	491,308
Operating lease liabilities 1		408,724			438,483
Total debt including operating lease liabilities (a)	$	956,351		$	929,791
Adjusted EBITDA (see above)	$	108,831		$	137,396
Consolidated rent expense		110,937			112,518
Consolidated EBITDAR (b)	$	219,768		$	249,914
Net Leverage Ratio under revolving credit facility (a divided by b)	4.4 to 1.0			3.7 to 1.0
1 Reflects operating lease liabilities included in our financial statements under ASC 842. The prior period has been updated to reflect this calculation.

Note - Our Net Leverage Ratio under Revolving Credit Facility, Adjusted EBITDA and EBITDAR calculations are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES Calculation of Return on Invested Capital (Adjusted ROIC) (in thousands)   Adjusted ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our adjusted invested capital. Management believes Adjusted ROIC is also a useful metric for investors and financial analysts. We compute Adjusted ROIC as outlined below. Our definition and calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:
	Trailing Twelve Months Ended
	June 29, 2024				July 1, 2023
Adjusted net operating profit after taxes (Adjusted NOPAT)
Operating (loss) income	$	(2,555	)		$	50,713
Add: Operating lease interest 1		27,750				27,040
Less: Income taxes 2		(6,104	)			(21,993	)
Adjusted NOPAT	$	19,091			$	55,760
Average adjusted invested capital
Total deficit	$	(446,964	)		$	(419,141	)
Add: Long-term debt 3		540,480				484,161
Add: Operating lease liabilities 4		408,724				438,483
Total adjusted invested capital at end of period	$	502,240			$	503,503
Average adjusted invested capital 5	$	509,369			$	452,573
Adjusted ROIC 6		3.7	%			12.3	%

1		Represents the interest expense component of lease expense included in our financial statements under ASC 842, Leases.
2		Reflects annual effective income tax rates, before discrete adjustments, of 24.2% and 28.3% for June 29, 2024 and July 1, 2023, respectively.
3		Long-term debt includes existing finance lease liabilities.
4		Reflects operating lease liabilities included in our financial statements under ASC 842.
5		Average adjusted invested capital represents the average of the last five fiscal quarters' ending adjusted invested capital balances.
6		Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital.
Note - The Company's Adjusted ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts. The Company updated its Adjusted ROIC calculation effective beginning with the reporting period ended December 31, 2022, to reflect adjustments consistent with ASC 842.
GAAP - generally accepted accounting principles in the U.S.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES Reported to Adjusted Statements of Operations Data Reconciliation (in thousands, except per share amounts)
	Three Months Ended
	June 29, 2024											July 1, 2023
	As Reported				Restructuring Costs 1,2			As Adjusted				As Reported
Operating income	$	6,120			$	1,819		$	7,939			$	11,226
Interest expense, net		12,270				—			12,270				9,948
(Loss) income before income taxes		(6,150	)			1,819			(4,331	)			1,278
Income tax (benefit) expense		(1,099	)			431			(668	)			524
Net (loss) income	$	(5,051	)		$	1,388		$	(3,663	)		$	754
Net (loss) income per share:
Basic	$	(0.22	)		$	0.06		$	(0.16	)		$	0.03
Diluted	$	(0.22	)		$	0.06		$	(0.16	)		$	0.03
Basic Shares		22,614				22,614			22,614				22,460
Diluted Shares		22,614				22,614			22,614				22,502

	Six Months Ended
	June 29, 2024											July 1, 2023
	As Reported				Restructuring Costs 1,2			As Adjusted				As Reported
Operating income	$	11,662			$	12,419		$	24,081			$	37,159
Interest expense, net		24,569				—			24,569				19,050
(Loss) income before income taxes		(12,907	)			12,419			(488	)			18,109
Income tax (benefit) expense		(374	)			2,943			2,569				5,890
Net (loss) income	$	(12,533	)		$	9,476		$	(3,057	)		$	12,219
Net (loss) income per share:
Basic	$	(0.56	)		$	0.42		$	(0.14	)		$	0.55
Diluted	$	(0.56	)		$	0.42		$	(0.14	)		$	0.54
Basic Shares		22,560				22,560			22,560				22,378
Diluted Shares		22,560				22,560			22,560				22,543

1		Represents costs related to business restructuring actions initiated in the fourth quarter of fiscal 2023.
2		The income tax expense is calculated using the estimated U.S. federal and state statutory tax rate of 23.7%.

Note - Our "as adjusted" data is considered a non-GAAP financial measure and is not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates year-over-year comparisons for investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240731365319/en/

Investor Contact: Dave Schwantes; (763) 551-7498; investorrelations@sleepnumber.com

Media Contact: Julie Elepano; (414) 732-9840; julie.elepano@sleepnumber.com

Source: Sleep Number Corporation

FAQ

What was Sleep Number's (SNBR) adjusted EBITDA for Q2 2024?

Sleep Number (SNBR) reported an adjusted EBITDA of $28 million for Q2 2024.

How did Sleep Number's (SNBR) gross margin rate change in Q2 2024?

Sleep Number's (SNBR) gross margin rate improved to 59.1% in Q2 2024, up 150 basis points compared to the same quarter last year.

What is Sleep Number's (SNBR) full-year 2024 adjusted EBITDA outlook?

Sleep Number (SNBR) reiterated its full-year 2024 adjusted EBITDA outlook of $125 million to $145 million.

How much did Sleep Number (SNBR) reduce its operating expenses in Q2 2024?

Sleep Number (SNBR) reduced its operating expenses by $19 million in Q2 2024 compared to the same quarter last year.

What is Sleep Number's (SNBR) free cash flow projection for 2024?

Sleep Number (SNBR) projects to generate $50 million to $70 million of free cash flow for the full year 2024.